Alyeska Investment Group
AGL icon

Alyeska Investment Group’s Agilon Health AGL Stock Holding History

Alyeska Investment Group’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-16,929
Closed -$7.34M – 484
2023
Q2 		$7.34M Buy
+16,929
New +$9.51M 0.05% 303
2021
Q3 		– Sell
-5,440
Closed -$5.52M – 672
2021
Q2 		$5.52M Buy
+5,440
New +$4.77M 0.06% 320

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Alyeska Investment Group's AGL Position: Q3 2023 in Review

Alyeska Investment Group sold out of Agilon Health (AGL) in Q3 2023, closing a stake of 16,929 shares — an estimated $7.34M sold.

Alyeska Investment Group first reported a position in AGL in Q2 2021 and held it in 2 quarters. The position peaked at $7.34M in Q2 2023. 177 funds tracked by Wall St. Rank hold AGL as of Q3 2023.

  • Alyeska Investment Group reported no remaining Agilon Health position as of Q3 2023 after selling out during the quarter.
  • Alyeska Investment Group sold 16,929 Agilon Health shares in Q3 2023, an estimated $7.34M.
  • Alyeska Investment Group first reported a position in Agilon Health in Q2 2021 and held it in 2 quarters.
  • Alyeska Investment Group's Agilon Health position peaked at $7.34M in Q2 2023.
  • 177 funds tracked by Wall St. Rank held Agilon Health as of Q3 2023.

Based on Alyeska Investment Group's 13F filing for Q3 2023, filed 14 Nov 2023.